Related Experiment Video
Updated: Jun 14, 2026
Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Bacteria in cancer therapy: a novel experimental strategy
S Patyar1, R Joshi, D S Prasad Byrav
1Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Abstract:
Resistance to conventional anticancer therapies in patients with advanced solid tumors has prompted the need of alternative cancer therapies. Moreover, the success of novel cancer therapies depends on their selectivity for cancer cells with limited toxicity to normal tissues. Several decades after Coley's work a variety of natural and genetically modified non-pathogenic bacterial species are being explored as potential antitumor agents, either to provide direct tumoricidal effects or to deliver tumoricidal molecules. Live, attenuated or genetically modified non-pathogenic bacterial species are capable of multiplying selectively in tumors and inhibiting their growth. Due to their selectivity for tumor tissues, these bacteria and their spores also serve as ideal vectors for delivering therapeutic proteins to tumors. Bacterial toxins too have emerged as promising cancer treatment strategy. The most potential and promising strategy is bacteria based gene-directed enzyme prodrug therapy. Although it has shown successful results in vivo yet further investigation about the targeting mechanisms of the bacteria are required to make it a complete therapeutic approach in cancer treatment.
Insights
Exploring non-pathogenic bacteria as novel cancer therapies offers a promising alternative for advanced solid tumors. These bacteria selectively target tumors, inhibiting growth and delivering therapeutic molecules with reduced toxicity.
Area of Science:
- Oncology
- Microbiology
- Biotechnology
Background:
- Conventional anticancer therapies face resistance in advanced solid tumors.
- Novel cancer therapies require selectivity for cancer cells and limited toxicity to normal tissues.
- Non-pathogenic bacteria are being investigated as potential antitumor agents.
Purpose of the Study:
- To explore the potential of non-pathogenic bacteria as a novel cancer therapy.
- To evaluate bacteria as direct tumoricidal agents or delivery vectors for therapeutic molecules.
- To assess bacteria-based gene-directed enzyme prodrug therapy for cancer treatment.
Main Methods:
- Utilizing live, attenuated, or genetically modified non-pathogenic bacterial species.
- Employing bacteria as selective tumor-targeting agents.
- Investigating bacteria as vectors for delivering therapeutic proteins and toxins.
- Exploring bacteria-based gene-directed enzyme prodrug therapy.
Main Results:
- Non-pathogenic bacteria can multiply selectively in tumors, inhibiting their growth.
- Bacteria serve as effective vectors for delivering therapeutic proteins and toxins to tumors.
- Bacteria-based gene-directed enzyme prodrug therapy shows successful in vivo results.
Conclusions:
- Non-pathogenic bacteria represent a promising alternative cancer therapy for solid tumors.
- Bacterial selectivity for tumors minimizes toxicity to normal tissues.
- Further research into bacterial targeting mechanisms is needed for complete therapeutic application.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...